1716 related articles for article (PubMed ID: 28631387)
21. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
22. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
Fraser A; Poole P
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
24. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
Chong J; Karner C; Poole P
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
[TBL] [Abstract][Full Text] [Related]
25. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Walters JA; Tan DJ; White CJ; Gibson PG; Wood-Baker R; Walters EH
Cochrane Database Syst Rev; 2014 Sep; (9):CD001288. PubMed ID: 25178099
[TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Chong J; Leung B; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD002309. PubMed ID: 24190161
[TBL] [Abstract][Full Text] [Related]
27. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
[TBL] [Abstract][Full Text] [Related]
28. Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease.
Yang IA; Ferry OR; Clarke MS; Sim EH; Fong KM
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD002991. PubMed ID: 36971693
[TBL] [Abstract][Full Text] [Related]
29. Macrolides versus placebo for chronic asthma.
Undela K; Goldsmith L; Kew KM; Ferrara G
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD002997. PubMed ID: 34807989
[TBL] [Abstract][Full Text] [Related]
30. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Sathananthan K; Fortescue R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
[TBL] [Abstract][Full Text] [Related]
31. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.
Kew KM; Seniukovich A
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010115. PubMed ID: 24615270
[TBL] [Abstract][Full Text] [Related]
32. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
Oba Y; Keeney E; Ghatehorde N; Dias S
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
[TBL] [Abstract][Full Text] [Related]
33. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
Kew KM; Evans DJ; Allison DE; Boyter AC
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
[TBL] [Abstract][Full Text] [Related]
34. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.
Geake JB; Dabscheck EJ; Wood-Baker R; Cates CJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010139. PubMed ID: 25575340
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary rehabilitation for chronic obstructive pulmonary disease.
McCarthy B; Casey D; Devane D; Murphy K; Murphy E; Lacasse Y
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD003793. PubMed ID: 25705944
[TBL] [Abstract][Full Text] [Related]
36. Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
Rojas-Reyes MX; García Morales OM; Dennis RJ; Karner C
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD008532. PubMed ID: 27271056
[TBL] [Abstract][Full Text] [Related]
37. Beclometasone for chronic obstructive pulmonary disease.
De Coster DA; Jones M; Thakrar N
Cochrane Database Syst Rev; 2013 Oct; (10):CD009769. PubMed ID: 24105424
[TBL] [Abstract][Full Text] [Related]
38. Statins versus placebo for people with chronic obstructive pulmonary disease.
Walsh A; Perrem L; Khashan AS; Henry MT; Ni Chroinin M
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011959. PubMed ID: 31425628
[TBL] [Abstract][Full Text] [Related]
39. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
Anderson DE; Kew KM; Boyter AC
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
[TBL] [Abstract][Full Text] [Related]
40. Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.
Gendron LM; Nyberg A; Saey D; Maltais F; Lacasse Y
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012290. PubMed ID: 30306545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]